BEIJING HOTGEN BIOTECH CO., LTD. Beijing Hotgen Biotech Co., Ltd. Share Price
Equities
688068
CNE100003P82
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.44 CNY | +1.68% |
|
+3.38% | -30.72% |
| 16/04 | Beijing Hotgen Biotech to Buy Kaijing Gene Technology for 11 Million Yuan | MT |
| 03/04 | Tranche Update on Beijing Hotgen Biotech Co., Ltd.'s Equity Buyback Plan announced on February 8, 2024. | CI |
| Sales 2021 | 5.37B 742M 61.87B | Sales 2022 | 3.56B 491M 40.98B | Capitalization | 5.61B 774M 64.59B |
|---|---|---|---|---|---|
| Net income 2021 | 2.19B 302M 25.19B | Net income 2022 | 945M 131M 10.89B | EV / Sales 2021 | 0.96 x |
| Net cash position 2021 | 2.05B 283M 23.65B | Net cash position 2022 | 1.42B 196M 16.36B | EV / Sales 2022 | 1.18 x |
| P/E ratio 2021 |
3.31
x | P/E ratio 2022 |
5.92
x | Employees | - |
| Yield 2021 |
4.3% | Yield 2022 |
-
| Free-Float | 61.07% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.68% | ||
| 1 week | +3.38% | ||
| Current month | -6.94% | ||
| 1 month | -5.89% | ||
| 3 months | -15.36% | ||
| 6 months | -30.89% | ||
| Current year | -30.72% |
1 week
27.30
28.50
1 month
26.8531.77
Current year
23.6741.68
1 year
23.6755.88
3 years
23.67164.86
5 years
23.18164.86
10 years
23.18164.86
| Managers | Title | Age | Since |
|---|---|---|---|
Chang Qing Lin
CEO | Chief Executive Officer | 48 | 23/05/23 |
Jing Li
CHM | Chairman | 46 | 01/06/01 |
Yong Zhan Shi
DFI | Director of Finance/CFO | 42 | 01/15/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Chang Qing Lin
CEO | Chief Executive Officer | 48 | 23/05/23 |
Xin Zhou
BRD | Director/Board Member | 62 | 01/15/01 |
Shao Hua Yu
BRD | Director/Board Member | 45 | 01/05/01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.05% | 12 M€ | -16.71% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 28.44 | +1.68% | 657,919 |
| 25/24/25 | 27.97 | +0.50% | 572,557 |
| 24/24/24 | 27.83 | +0.18% | 520,041 |
| 23/24/23 | 27.78 | +0.54% | 530,638 |
| 22/24/22 | 27.63 | +0.44% | 551,544 |
End-of-day quote Shanghai S.E., April 26, 2024
More quotes
Beijing Hotgen Biotech Co Ltd is a China-based company mainly engaged in the research and development, production and sales of in vitro diagnostic reagents and instruments. The Company's products mainly include in vitro diagnostic reagents, in vitro diagnostic instruments and biological raw materials. Its products are mainly used in clinical fields such as liver cancer, hepatitis, cardiovascular and cerebrovascular diseases, and inflammatory infections, as well as in public safety and other fields such as biosafety, food safety, and disease control and emergency response. The Company primarily conducts its businesses in domestic and overseas markets.
Calendar
30/04/2024
- Q1 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -30.72% | 351M | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.07% | 26.48B | |
| +2.36% | 26.25B | |
| +12.96% | 24.62B |
- Stock Market
- Equities
- 688068 Stock
